High-Intensity Focused Ultrasound Offers Immediate Relief for Essential Tremor - Top-Institutions - MDSpire

High-Intensity Focused Ultrasound Offers Immediate Relief for Essential Tremor

Essential tremor is a neurological disorder that causes involuntary, rhythmic shaking. Unlike the tremors associated with Parkinson's disease, ET is typically an “action tremor.”

  • March 5, 2026

  • 7 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Neurosurgery
    • Functional Neurosurgery

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Neurosurgery
    • Movement Disorders

  • #3

    Baptist Health Miami Neuroscience Institute
    Baptist Health Miami Neuroscience Institute

    Miami, FL

    Key Differentiators

    • Neurosurgery
    • Neurology
    • Functional Neurosurgery

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Neurosurgery
    • Movement Disorders

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Neurosurgery
    • Functional Neurosurgery

Original Source(s)

High-Intensity Focused Ultrasound Offers Immediate Relief for Essential Tremor

  • March 5, 2026

Related Content

ASCO26: Alicia Morgans, MD, MPH, ARACOG

Dr. Alicia Morgans of Dana-Farber Cancer Institute reported at #ASCO26 that ARACOG found darolutamide was associated with less decline in cognitive testing than enzalutamide, which may help guide treatment choice.

  • July 1, 2026

  • 1 min
This Week’s CGT News: Radiopharmaceutical Boosts CAR T

A targeted radiopharmaceutical improves CAR T activity in neuroblastoma models, engineered Tregs suppress allergic asthma, and new gene therapy platforms target MMA and the brain

  • July 13, 2026

  • 5 min
Head-to-Head Trial in Relapsing MS

The phase 3 OVERLORD-MS trial compared 2 anti-CD20 therapies in previously untreated adults with newly diagnosed relapsing multiple sclerosis and recent inflammatory disease activity.